These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 16586550)
21. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori. Altintas E; Sezgin O; Ulu O; Aydin O; Camdeviren H World J Gastroenterol; 2004 Jun; 10(11):1656-8. PubMed ID: 15162544 [TBL] [Abstract][Full Text] [Related]
22. Omeprazole plus clarithromycin and either tinidazole or tetracycline for Helicobacter pylori infection: a randomized prospective study. Zullo A; Rinaldi V; Pugliano F; Diana F; Attili AF Am J Gastroenterol; 1997 Nov; 92(11):2029-31. PubMed ID: 9362185 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study. Demiray M; Gulten M; Manavoglu O; Evrensel T; Ulukaya E; Yerci O; Kanat O; Kurt E; Arslan M; Gonullu G; Demiray H; Gulten T; Memik F Hepatogastroenterology; 2004; 51(59):1531-5. PubMed ID: 15362794 [TBL] [Abstract][Full Text] [Related]
24. A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection. Trevisani L; Sartori S; Caselli M; Ruina M; Verdianelli G; Abbasciano V Am J Gastroenterol; 1998 Mar; 93(3):390-3. PubMed ID: 9517646 [TBL] [Abstract][Full Text] [Related]
25. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer]. Buzás György M; Székely E; Illyés G; Széles I Orv Hetil; 2000 Jul; 141(31):1711-4. PubMed ID: 10976194 [TBL] [Abstract][Full Text] [Related]
26. Endoscopic, histological and serologic findings of gastric hyperplastic polyps after eradication of Helicobacter pylori: comparison between responder and non-responder cases. Ohkusa T; Miwa H; Hojo M; Kumagai J; Tanizawa T; Asaoka D; Terai T; Ohkura R; Sato N Digestion; 2003; 68(2-3):57-62. PubMed ID: 14581761 [TBL] [Abstract][Full Text] [Related]
28. Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study. Chaudhary A; Ahuja V; Bal CS; Das B; Pandey RM; Sharma MP Helicobacter; 2004 Apr; 9(2):124-9. PubMed ID: 15068413 [TBL] [Abstract][Full Text] [Related]
29. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy. Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043 [TBL] [Abstract][Full Text] [Related]
30. Helicobacter pylori Eradication Regressed Gastric Hyperplastic Polyp: A Randomized Controlled Trial. Nam SY; Lee SW; Jeon SW; Kwon YH; Lee HS Dig Dis Sci; 2020 Dec; 65(12):3652-3659. PubMed ID: 31974914 [TBL] [Abstract][Full Text] [Related]
31. Dual therapy with lansoprazole and clarithromycin for eradication of Helicobacter pylori. Takimoto T; Kimura K; Taniguchi Y; Satoh K; Saifuku K; Kihira K; Yoshida Y; Ido K Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S63-6. PubMed ID: 8574739 [TBL] [Abstract][Full Text] [Related]
32. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic]. Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978 [TBL] [Abstract][Full Text] [Related]
33. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452 [TBL] [Abstract][Full Text] [Related]
34. Endoscopic and histological reversibility of gastric adenoma after eradication of Helicobacter pylori. Gotoda T; Saito D; Kondo H; Ono H; Oda I; Fujishiro M; Yamaguchi H J Gastroenterol; 1999; 34 Suppl 11():91-6. PubMed ID: 10616774 [TBL] [Abstract][Full Text] [Related]
35. [Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers]. Lamouliatte H; Perie F; Joubert-Collin M Gastroenterol Clin Biol; 2000 May; 24(5):495-500. PubMed ID: 10891736 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of the efficacy of triple therapy regimen for Helicobacter pylori eradication in gastrectomized patients with gastric adenocarcinoma. Bertoli Neto JL; Lourenço LG; Bertoli CF; Ulbrich FS; Sabbi AR; Bueno AG Gastric Cancer; 2006; 9(4):291-4. PubMed ID: 17235631 [TBL] [Abstract][Full Text] [Related]
37. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori. Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974 [TBL] [Abstract][Full Text] [Related]
38. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol. Ushiama H; Echizen H; Nachi S; Ohnishi A Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002 [TBL] [Abstract][Full Text] [Related]
39. [Gastric hyperplastic polyps and H. pylori infection, their relationship and effects of eradication therapy]. Tokunaga K; Tanaka A; Takahashi S Nihon Rinsho; 2013 Aug; 71(8):1449-52. PubMed ID: 23967678 [TBL] [Abstract][Full Text] [Related]
40. Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer. Lazzaroni M; Bargiggia S; Bianchi Porro G Am J Gastroenterol; 1997 Apr; 92(4):649-52. PubMed ID: 9128316 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]